Supported by a grant from the Korea Healthcare Technology R&D Project (A080588), Ministry for Health, Welfare & Family Affairs, Republic of Korea.
Prospective evaluation of the clinical utility of interferon-γ assay in the differential diagnosis of intestinal tuberculosis and Crohn's disease†
Article first published online: 25 OCT 2010
Copyright © 2010 Crohn's & Colitis Foundation of America, Inc.
Inflammatory Bowel Diseases
Volume 17, Issue 6, pages 1308–1313, June 2011
How to Cite
Kim, B. J., Choi, Y. S., Jang, B. I., Park, Y. S., Kim, W. H., Kim, Y. S., Jung, S.-A., Han, D. S., Kim, J. S., Choi, J. H., Choi, C. H., Jeen, Y. T., Cheon, J. H., Ye, B. D., Yang, S.-K. and Kim, Y.-H. (2011), Prospective evaluation of the clinical utility of interferon-γ assay in the differential diagnosis of intestinal tuberculosis and Crohn's disease. Inflamm Bowel Dis, 17: 1308–1313. doi: 10.1002/ibd.21490
- Issue published online: 10 MAY 2011
- Article first published online: 25 OCT 2010
- Manuscript Received: 18 AUG 2010
- Manuscript Accepted: 18 AUG 2010
- 4An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008; 103: 3167–3182., , , et al.Direct Link:
- 8Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep. 2005; 54: 49–55., , , et al.
- 16Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French research axed on tolerance of biotherapies registry. Arthritis Rheum. 2009; 60: 1884–1894., , , et al.